Global Diagnostic Technology Market
Global Diagnostic Technology Market

Diagnostic Technology Comprehensive Study by Type (Immunoassay/Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation and Hemostasis, Urinalysis, Other IVD Technologies), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, Drug Testing/Pharmacogenomics, HIV/Aids, Others), End User (Hospitals, Laboratories, Point-Of-Care Testing, Patient Self-Testing, Academic Institutes, Others) Players and Region - Global Market Outlook to 2024

Diagnostic Technology Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

Feb 2019 Edition 150 Pages 182 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Diagnostic Technology Market Overview:
Identification of a disease, condition, disorder, or problem by systematic analysis of the background or history, examination of the signs or symptoms, evaluation of the research or test results, and investigation of the assumed or probable causes. Effective prognosis is not possible without an effective diagnosis. Diagnostic technology has been proven as the most effective technology in the field of healthcare and gained significant importance across the globe. Diagnostic technology has resolved many issues such as data errors, complexities, and other outcomes. It is aiming for escalating the volume of molecular insights and translating it into products with high medical significance for physicians and patients. Some of the key players profiled in the study are Roche Diagnostics SpA (Italy), Danaher Corporation (United States), Abbott Laboratories, Inc. (United States), Siemens AG (United States), Sysmex Corporation (Japan), Thermo Fisher Scientific (United States), Becton, Dickinson, and Company (United States), Biomérieux SA (France), Bio-Rad Laboratories, Inc. (France) and Johnson & Johnson (United States).

On the basis of geography, the market of Diagnostic Technology has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End User, the sub-segment i.e. Hospitals will boost the Diagnostic Technology market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Rising Geriatric Population
  • The Rising Prevalence of Infectious and Chronic Diseases
  • Growing Awareness of Personalized Medicine
  • Increasing Adoption of Point-Of-Care Testing
  • Growing Awareness Regarding Preventive Care


Restraints
  • Critical Reimbursement Scenario

Opportunities
  • Development of Condition-Specific Markers and Tests
  • Growing Importance of Companion Diagnostics
  • Emerging Demand from Economies

Challenges
  • Operational Obstacles Faced in Conducting Diagnostic Tests
  • Changing Regulatory Landscape


On 3 Aug 2018, Sysmex Corporation and JVCKENWOOD Corporation have reached an agreement to jointly establish a new company, Creative Nanosystems Corporation, to develop and manufacture bio devices. These in vitro diagnostic devices will consist of microfluidics to achieve rapid reactions amongst tiny amounts of specimens and reagents. and On 9 March 2018, Danaher Corp., a leading diagnostic technology firm and Integrated DNA Technologies, have announced a definitive agreement to acquire IDT, a privately-held provider of high-value consumables for genomics applications in molecular biology, next-generation sequencing, qPCR, synthetic biology, gene editing and molecular diagnostics.


Target Audience:
Diagnostic Technology Companies, Group Purchase Organizations (GPOs), OEM Manufacturers, Pathologists and Pathology Laboratories, Distributors of IVD Products, Hospitals and Clinics, Healthcare Institutions, Research Institutes, Market Research and Consulting Firms and Venture Capitalists and Investors

Major Objectives Focused through this Study
• To define, describe, and forecast the Global Diagnostic Technology market on the basis of product [Immunoassay/Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation and Hemostasis, Urinalysis and Other IVD Technologies] , application [Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, Drug Testing/Pharmacogenomics, HIV/Aids and Others], key regions and end user
• To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
• To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
• Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
• To provide market size for various segments of the Diagnostic Technology market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
• To strategically profile the key players and analyzing their market shares and core competencies in the Diagnostic Technology industry
• To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are Diagnostic Technology Pty. Ltd. (Australia), Agilent Technologies (United States), QIAGEN GmbH (Germany), Diasorin S.p.A (Italy) and Ortho Clinical Diagnostics (A Part of Carlyle Group) (United States).
** Confirmation on availability of data would be informed prior purchase

While framing the research framework, major and emerging players operating in the Diagnostic Technology market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.
Report Objectives / Segmentation Covered
By Type
  • Immunoassay/Immunochemistry
  • Clinical Chemistry
  • Molecular Diagnostics
  • Microbiology
  • Hematology
  • Coagulation and Hemostasis
  • Urinalysis
  • Other IVD Technologies
By Application
  • Infectious Diseases
  • Diabetes
  • Oncology
  • Cardiology
  • Autoimmune Diseases
  • Nephrology
  • Drug Testing/Pharmacogenomics
  • HIV/Aids
  • Others
By End User
  • Hospitals
  • Laboratories
  • Point-Of-Care Testing
  • Patient Self-Testing
  • Academic Institutes
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Geriatric Population
      • 3.2.2. The Rising Prevalence of Infectious and Chronic Diseases
      • 3.2.3. Growing Awareness of Personalized Medicine
      • 3.2.4. Increasing Adoption of Point-Of-Care Testing
      • 3.2.5. Growing Awareness Regarding Preventive Care
    • 3.3. Market Challenges
      • 3.3.1. Operational Obstacles Faced in Conducting Diagnostic Tests
      • 3.3.2. Changing Regulatory Landscape
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Diagnostic Technology, by Type, Application, End User and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Diagnostic Technology (Value)
      • 5.2.1. Global Diagnostic Technology by: Type (Value)
        • 5.2.1.1. Immunoassay/Immunochemistry
        • 5.2.1.2. Clinical Chemistry
        • 5.2.1.3. Molecular Diagnostics
        • 5.2.1.4. Microbiology
        • 5.2.1.5. Hematology
        • 5.2.1.6. Coagulation and Hemostasis
        • 5.2.1.7. Urinalysis
        • 5.2.1.8. Other IVD Technologies
      • 5.2.2. Global Diagnostic Technology by: Application (Value)
        • 5.2.2.1. Infectious Diseases
        • 5.2.2.2. Diabetes
        • 5.2.2.3. Oncology
        • 5.2.2.4. Cardiology
        • 5.2.2.5. Autoimmune Diseases
        • 5.2.2.6. Nephrology
        • 5.2.2.7. Drug Testing/Pharmacogenomics
        • 5.2.2.8. HIV/Aids
        • 5.2.2.9. Others
      • 5.2.3. Global Diagnostic Technology by: End User (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Laboratories
        • 5.2.3.3. Point-Of-Care Testing
        • 5.2.3.4. Patient Self-Testing
        • 5.2.3.5. Academic Institutes
        • 5.2.3.6. Others
      • 5.2.4. Global Diagnostic Technology Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Diagnostic Technology: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Roche Diagnostics SpA (Italy)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Danaher Corporation (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Abbott Laboratories, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Siemens AG (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Sysmex Corporation (Japan)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Thermo Fisher Scientific (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Becton, Dickinson, and Company (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Biomérieux SA (France)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Bio-Rad Laboratories, Inc. (France)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Johnson & Johnson (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Diagnostic Technology Sale, by Type, Application, End User and Region (value) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Diagnostic Technology (Value)
      • 7.2.1. Global Diagnostic Technology by: Type (Value)
        • 7.2.1.1. Immunoassay/Immunochemistry
        • 7.2.1.2. Clinical Chemistry
        • 7.2.1.3. Molecular Diagnostics
        • 7.2.1.4. Microbiology
        • 7.2.1.5. Hematology
        • 7.2.1.6. Coagulation and Hemostasis
        • 7.2.1.7. Urinalysis
        • 7.2.1.8. Other IVD Technologies
      • 7.2.2. Global Diagnostic Technology by: Application (Value)
        • 7.2.2.1. Infectious Diseases
        • 7.2.2.2. Diabetes
        • 7.2.2.3. Oncology
        • 7.2.2.4. Cardiology
        • 7.2.2.5. Autoimmune Diseases
        • 7.2.2.6. Nephrology
        • 7.2.2.7. Drug Testing/Pharmacogenomics
        • 7.2.2.8. HIV/Aids
        • 7.2.2.9. Others
      • 7.2.3. Global Diagnostic Technology by: End User (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Laboratories
        • 7.2.3.3. Point-Of-Care Testing
        • 7.2.3.4. Patient Self-Testing
        • 7.2.3.5. Academic Institutes
        • 7.2.3.6. Others
      • 7.2.4. Global Diagnostic Technology Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Diagnostic Technology: by Type(USD Million)
  • Table 2. Diagnostic Technology Immunoassay/Immunochemistry , by Region USD Million (2013-2018)
  • Table 3. Diagnostic Technology Clinical Chemistry , by Region USD Million (2013-2018)
  • Table 4. Diagnostic Technology Molecular Diagnostics , by Region USD Million (2013-2018)
  • Table 5. Diagnostic Technology Microbiology , by Region USD Million (2013-2018)
  • Table 6. Diagnostic Technology Hematology , by Region USD Million (2013-2018)
  • Table 7. Diagnostic Technology Coagulation and Hemostasis , by Region USD Million (2013-2018)
  • Table 8. Diagnostic Technology Urinalysis , by Region USD Million (2013-2018)
  • Table 9. Diagnostic Technology Other IVD Technologies , by Region USD Million (2013-2018)
  • Table 10. Diagnostic Technology: by Application(USD Million)
  • Table 11. Diagnostic Technology Infectious Diseases , by Region USD Million (2013-2018)
  • Table 12. Diagnostic Technology Diabetes , by Region USD Million (2013-2018)
  • Table 13. Diagnostic Technology Oncology , by Region USD Million (2013-2018)
  • Table 14. Diagnostic Technology Cardiology , by Region USD Million (2013-2018)
  • Table 15. Diagnostic Technology Autoimmune Diseases , by Region USD Million (2013-2018)
  • Table 16. Diagnostic Technology Nephrology , by Region USD Million (2013-2018)
  • Table 17. Diagnostic Technology Drug Testing/Pharmacogenomics , by Region USD Million (2013-2018)
  • Table 18. Diagnostic Technology HIV/Aids , by Region USD Million (2013-2018)
  • Table 19. Diagnostic Technology Others , by Region USD Million (2013-2018)
  • Table 20. Diagnostic Technology: by End User(USD Million)
  • Table 21. Diagnostic Technology Hospitals , by Region USD Million (2013-2018)
  • Table 22. Diagnostic Technology Laboratories , by Region USD Million (2013-2018)
  • Table 23. Diagnostic Technology Point-Of-Care Testing , by Region USD Million (2013-2018)
  • Table 24. Diagnostic Technology Patient Self-Testing , by Region USD Million (2013-2018)
  • Table 25. Diagnostic Technology Academic Institutes , by Region USD Million (2013-2018)
  • Table 26. Diagnostic Technology Others , by Region USD Million (2013-2018)
  • Table 27. South America Diagnostic Technology, by Country USD Million (2013-2018)
  • Table 28. South America Diagnostic Technology, by Type USD Million (2013-2018)
  • Table 29. South America Diagnostic Technology, by Application USD Million (2013-2018)
  • Table 30. South America Diagnostic Technology, by End User USD Million (2013-2018)
  • Table 31. Brazil Diagnostic Technology, by Type USD Million (2013-2018)
  • Table 32. Brazil Diagnostic Technology, by Application USD Million (2013-2018)
  • Table 33. Brazil Diagnostic Technology, by End User USD Million (2013-2018)
  • Table 34. Argentina Diagnostic Technology, by Type USD Million (2013-2018)
  • Table 35. Argentina Diagnostic Technology, by Application USD Million (2013-2018)
  • Table 36. Argentina Diagnostic Technology, by End User USD Million (2013-2018)
  • Table 37. Rest of South America Diagnostic Technology, by Type USD Million (2013-2018)
  • Table 38. Rest of South America Diagnostic Technology, by Application USD Million (2013-2018)
  • Table 39. Rest of South America Diagnostic Technology, by End User USD Million (2013-2018)
  • Table 40. Asia Pacific Diagnostic Technology, by Country USD Million (2013-2018)
  • Table 41. Asia Pacific Diagnostic Technology, by Type USD Million (2013-2018)
  • Table 42. Asia Pacific Diagnostic Technology, by Application USD Million (2013-2018)
  • Table 43. Asia Pacific Diagnostic Technology, by End User USD Million (2013-2018)
  • Table 44. China Diagnostic Technology, by Type USD Million (2013-2018)
  • Table 45. China Diagnostic Technology, by Application USD Million (2013-2018)
  • Table 46. China Diagnostic Technology, by End User USD Million (2013-2018)
  • Table 47. Japan Diagnostic Technology, by Type USD Million (2013-2018)
  • Table 48. Japan Diagnostic Technology, by Application USD Million (2013-2018)
  • Table 49. Japan Diagnostic Technology, by End User USD Million (2013-2018)
  • Table 50. India Diagnostic Technology, by Type USD Million (2013-2018)
  • Table 51. India Diagnostic Technology, by Application USD Million (2013-2018)
  • Table 52. India Diagnostic Technology, by End User USD Million (2013-2018)
  • Table 53. South Korea Diagnostic Technology, by Type USD Million (2013-2018)
  • Table 54. South Korea Diagnostic Technology, by Application USD Million (2013-2018)
  • Table 55. South Korea Diagnostic Technology, by End User USD Million (2013-2018)
  • Table 56. Taiwan Diagnostic Technology, by Type USD Million (2013-2018)
  • Table 57. Taiwan Diagnostic Technology, by Application USD Million (2013-2018)
  • Table 58. Taiwan Diagnostic Technology, by End User USD Million (2013-2018)
  • Table 59. Australia Diagnostic Technology, by Type USD Million (2013-2018)
  • Table 60. Australia Diagnostic Technology, by Application USD Million (2013-2018)
  • Table 61. Australia Diagnostic Technology, by End User USD Million (2013-2018)
  • Table 62. Rest of Asia-Pacific Diagnostic Technology, by Type USD Million (2013-2018)
  • Table 63. Rest of Asia-Pacific Diagnostic Technology, by Application USD Million (2013-2018)
  • Table 64. Rest of Asia-Pacific Diagnostic Technology, by End User USD Million (2013-2018)
  • Table 65. Europe Diagnostic Technology, by Country USD Million (2013-2018)
  • Table 66. Europe Diagnostic Technology, by Type USD Million (2013-2018)
  • Table 67. Europe Diagnostic Technology, by Application USD Million (2013-2018)
  • Table 68. Europe Diagnostic Technology, by End User USD Million (2013-2018)
  • Table 69. Germany Diagnostic Technology, by Type USD Million (2013-2018)
  • Table 70. Germany Diagnostic Technology, by Application USD Million (2013-2018)
  • Table 71. Germany Diagnostic Technology, by End User USD Million (2013-2018)
  • Table 72. France Diagnostic Technology, by Type USD Million (2013-2018)
  • Table 73. France Diagnostic Technology, by Application USD Million (2013-2018)
  • Table 74. France Diagnostic Technology, by End User USD Million (2013-2018)
  • Table 75. Italy Diagnostic Technology, by Type USD Million (2013-2018)
  • Table 76. Italy Diagnostic Technology, by Application USD Million (2013-2018)
  • Table 77. Italy Diagnostic Technology, by End User USD Million (2013-2018)
  • Table 78. United Kingdom Diagnostic Technology, by Type USD Million (2013-2018)
  • Table 79. United Kingdom Diagnostic Technology, by Application USD Million (2013-2018)
  • Table 80. United Kingdom Diagnostic Technology, by End User USD Million (2013-2018)
  • Table 81. Netherlands Diagnostic Technology, by Type USD Million (2013-2018)
  • Table 82. Netherlands Diagnostic Technology, by Application USD Million (2013-2018)
  • Table 83. Netherlands Diagnostic Technology, by End User USD Million (2013-2018)
  • Table 84. Rest of Europe Diagnostic Technology, by Type USD Million (2013-2018)
  • Table 85. Rest of Europe Diagnostic Technology, by Application USD Million (2013-2018)
  • Table 86. Rest of Europe Diagnostic Technology, by End User USD Million (2013-2018)
  • Table 87. MEA Diagnostic Technology, by Country USD Million (2013-2018)
  • Table 88. MEA Diagnostic Technology, by Type USD Million (2013-2018)
  • Table 89. MEA Diagnostic Technology, by Application USD Million (2013-2018)
  • Table 90. MEA Diagnostic Technology, by End User USD Million (2013-2018)
  • Table 91. Middle East Diagnostic Technology, by Type USD Million (2013-2018)
  • Table 92. Middle East Diagnostic Technology, by Application USD Million (2013-2018)
  • Table 93. Middle East Diagnostic Technology, by End User USD Million (2013-2018)
  • Table 94. Africa Diagnostic Technology, by Type USD Million (2013-2018)
  • Table 95. Africa Diagnostic Technology, by Application USD Million (2013-2018)
  • Table 96. Africa Diagnostic Technology, by End User USD Million (2013-2018)
  • Table 97. North America Diagnostic Technology, by Country USD Million (2013-2018)
  • Table 98. North America Diagnostic Technology, by Type USD Million (2013-2018)
  • Table 99. North America Diagnostic Technology, by Application USD Million (2013-2018)
  • Table 100. North America Diagnostic Technology, by End User USD Million (2013-2018)
  • Table 101. United States Diagnostic Technology, by Type USD Million (2013-2018)
  • Table 102. United States Diagnostic Technology, by Application USD Million (2013-2018)
  • Table 103. United States Diagnostic Technology, by End User USD Million (2013-2018)
  • Table 104. Canada Diagnostic Technology, by Type USD Million (2013-2018)
  • Table 105. Canada Diagnostic Technology, by Application USD Million (2013-2018)
  • Table 106. Canada Diagnostic Technology, by End User USD Million (2013-2018)
  • Table 107. Mexico Diagnostic Technology, by Type USD Million (2013-2018)
  • Table 108. Mexico Diagnostic Technology, by Application USD Million (2013-2018)
  • Table 109. Mexico Diagnostic Technology, by End User USD Million (2013-2018)
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Company Basic Information, Sales Area and Its Competitors
  • Table 114. Company Basic Information, Sales Area and Its Competitors
  • Table 115. Company Basic Information, Sales Area and Its Competitors
  • Table 116. Company Basic Information, Sales Area and Its Competitors
  • Table 117. Company Basic Information, Sales Area and Its Competitors
  • Table 118. Company Basic Information, Sales Area and Its Competitors
  • Table 119. Company Basic Information, Sales Area and Its Competitors
  • Table 120. Diagnostic Technology: by Type(USD Million)
  • Table 121. Diagnostic Technology Immunoassay/Immunochemistry , by Region USD Million (2019-2024)
  • Table 122. Diagnostic Technology Clinical Chemistry , by Region USD Million (2019-2024)
  • Table 123. Diagnostic Technology Molecular Diagnostics , by Region USD Million (2019-2024)
  • Table 124. Diagnostic Technology Microbiology , by Region USD Million (2019-2024)
  • Table 125. Diagnostic Technology Hematology , by Region USD Million (2019-2024)
  • Table 126. Diagnostic Technology Coagulation and Hemostasis , by Region USD Million (2019-2024)
  • Table 127. Diagnostic Technology Urinalysis , by Region USD Million (2019-2024)
  • Table 128. Diagnostic Technology Other IVD Technologies , by Region USD Million (2019-2024)
  • Table 129. Diagnostic Technology: by Application(USD Million)
  • Table 130. Diagnostic Technology Infectious Diseases , by Region USD Million (2019-2024)
  • Table 131. Diagnostic Technology Diabetes , by Region USD Million (2019-2024)
  • Table 132. Diagnostic Technology Oncology , by Region USD Million (2019-2024)
  • Table 133. Diagnostic Technology Cardiology , by Region USD Million (2019-2024)
  • Table 134. Diagnostic Technology Autoimmune Diseases , by Region USD Million (2019-2024)
  • Table 135. Diagnostic Technology Nephrology , by Region USD Million (2019-2024)
  • Table 136. Diagnostic Technology Drug Testing/Pharmacogenomics , by Region USD Million (2019-2024)
  • Table 137. Diagnostic Technology HIV/Aids , by Region USD Million (2019-2024)
  • Table 138. Diagnostic Technology Others , by Region USD Million (2019-2024)
  • Table 139. Diagnostic Technology: by End User(USD Million)
  • Table 140. Diagnostic Technology Hospitals , by Region USD Million (2019-2024)
  • Table 141. Diagnostic Technology Laboratories , by Region USD Million (2019-2024)
  • Table 142. Diagnostic Technology Point-Of-Care Testing , by Region USD Million (2019-2024)
  • Table 143. Diagnostic Technology Patient Self-Testing , by Region USD Million (2019-2024)
  • Table 144. Diagnostic Technology Academic Institutes , by Region USD Million (2019-2024)
  • Table 145. Diagnostic Technology Others , by Region USD Million (2019-2024)
  • Table 146. South America Diagnostic Technology, by Country USD Million (2019-2024)
  • Table 147. South America Diagnostic Technology, by Type USD Million (2019-2024)
  • Table 148. South America Diagnostic Technology, by Application USD Million (2019-2024)
  • Table 149. South America Diagnostic Technology, by End User USD Million (2019-2024)
  • Table 150. Brazil Diagnostic Technology, by Type USD Million (2019-2024)
  • Table 151. Brazil Diagnostic Technology, by Application USD Million (2019-2024)
  • Table 152. Brazil Diagnostic Technology, by End User USD Million (2019-2024)
  • Table 153. Argentina Diagnostic Technology, by Type USD Million (2019-2024)
  • Table 154. Argentina Diagnostic Technology, by Application USD Million (2019-2024)
  • Table 155. Argentina Diagnostic Technology, by End User USD Million (2019-2024)
  • Table 156. Rest of South America Diagnostic Technology, by Type USD Million (2019-2024)
  • Table 157. Rest of South America Diagnostic Technology, by Application USD Million (2019-2024)
  • Table 158. Rest of South America Diagnostic Technology, by End User USD Million (2019-2024)
  • Table 159. Asia Pacific Diagnostic Technology, by Country USD Million (2019-2024)
  • Table 160. Asia Pacific Diagnostic Technology, by Type USD Million (2019-2024)
  • Table 161. Asia Pacific Diagnostic Technology, by Application USD Million (2019-2024)
  • Table 162. Asia Pacific Diagnostic Technology, by End User USD Million (2019-2024)
  • Table 163. China Diagnostic Technology, by Type USD Million (2019-2024)
  • Table 164. China Diagnostic Technology, by Application USD Million (2019-2024)
  • Table 165. China Diagnostic Technology, by End User USD Million (2019-2024)
  • Table 166. Japan Diagnostic Technology, by Type USD Million (2019-2024)
  • Table 167. Japan Diagnostic Technology, by Application USD Million (2019-2024)
  • Table 168. Japan Diagnostic Technology, by End User USD Million (2019-2024)
  • Table 169. India Diagnostic Technology, by Type USD Million (2019-2024)
  • Table 170. India Diagnostic Technology, by Application USD Million (2019-2024)
  • Table 171. India Diagnostic Technology, by End User USD Million (2019-2024)
  • Table 172. South Korea Diagnostic Technology, by Type USD Million (2019-2024)
  • Table 173. South Korea Diagnostic Technology, by Application USD Million (2019-2024)
  • Table 174. South Korea Diagnostic Technology, by End User USD Million (2019-2024)
  • Table 175. Taiwan Diagnostic Technology, by Type USD Million (2019-2024)
  • Table 176. Taiwan Diagnostic Technology, by Application USD Million (2019-2024)
  • Table 177. Taiwan Diagnostic Technology, by End User USD Million (2019-2024)
  • Table 178. Australia Diagnostic Technology, by Type USD Million (2019-2024)
  • Table 179. Australia Diagnostic Technology, by Application USD Million (2019-2024)
  • Table 180. Australia Diagnostic Technology, by End User USD Million (2019-2024)
  • Table 181. Rest of Asia-Pacific Diagnostic Technology, by Type USD Million (2019-2024)
  • Table 182. Rest of Asia-Pacific Diagnostic Technology, by Application USD Million (2019-2024)
  • Table 183. Rest of Asia-Pacific Diagnostic Technology, by End User USD Million (2019-2024)
  • Table 184. Europe Diagnostic Technology, by Country USD Million (2019-2024)
  • Table 185. Europe Diagnostic Technology, by Type USD Million (2019-2024)
  • Table 186. Europe Diagnostic Technology, by Application USD Million (2019-2024)
  • Table 187. Europe Diagnostic Technology, by End User USD Million (2019-2024)
  • Table 188. Germany Diagnostic Technology, by Type USD Million (2019-2024)
  • Table 189. Germany Diagnostic Technology, by Application USD Million (2019-2024)
  • Table 190. Germany Diagnostic Technology, by End User USD Million (2019-2024)
  • Table 191. France Diagnostic Technology, by Type USD Million (2019-2024)
  • Table 192. France Diagnostic Technology, by Application USD Million (2019-2024)
  • Table 193. France Diagnostic Technology, by End User USD Million (2019-2024)
  • Table 194. Italy Diagnostic Technology, by Type USD Million (2019-2024)
  • Table 195. Italy Diagnostic Technology, by Application USD Million (2019-2024)
  • Table 196. Italy Diagnostic Technology, by End User USD Million (2019-2024)
  • Table 197. United Kingdom Diagnostic Technology, by Type USD Million (2019-2024)
  • Table 198. United Kingdom Diagnostic Technology, by Application USD Million (2019-2024)
  • Table 199. United Kingdom Diagnostic Technology, by End User USD Million (2019-2024)
  • Table 200. Netherlands Diagnostic Technology, by Type USD Million (2019-2024)
  • Table 201. Netherlands Diagnostic Technology, by Application USD Million (2019-2024)
  • Table 202. Netherlands Diagnostic Technology, by End User USD Million (2019-2024)
  • Table 203. Rest of Europe Diagnostic Technology, by Type USD Million (2019-2024)
  • Table 204. Rest of Europe Diagnostic Technology, by Application USD Million (2019-2024)
  • Table 205. Rest of Europe Diagnostic Technology, by End User USD Million (2019-2024)
  • Table 206. MEA Diagnostic Technology, by Country USD Million (2019-2024)
  • Table 207. MEA Diagnostic Technology, by Type USD Million (2019-2024)
  • Table 208. MEA Diagnostic Technology, by Application USD Million (2019-2024)
  • Table 209. MEA Diagnostic Technology, by End User USD Million (2019-2024)
  • Table 210. Middle East Diagnostic Technology, by Type USD Million (2019-2024)
  • Table 211. Middle East Diagnostic Technology, by Application USD Million (2019-2024)
  • Table 212. Middle East Diagnostic Technology, by End User USD Million (2019-2024)
  • Table 213. Africa Diagnostic Technology, by Type USD Million (2019-2024)
  • Table 214. Africa Diagnostic Technology, by Application USD Million (2019-2024)
  • Table 215. Africa Diagnostic Technology, by End User USD Million (2019-2024)
  • Table 216. North America Diagnostic Technology, by Country USD Million (2019-2024)
  • Table 217. North America Diagnostic Technology, by Type USD Million (2019-2024)
  • Table 218. North America Diagnostic Technology, by Application USD Million (2019-2024)
  • Table 219. North America Diagnostic Technology, by End User USD Million (2019-2024)
  • Table 220. United States Diagnostic Technology, by Type USD Million (2019-2024)
  • Table 221. United States Diagnostic Technology, by Application USD Million (2019-2024)
  • Table 222. United States Diagnostic Technology, by End User USD Million (2019-2024)
  • Table 223. Canada Diagnostic Technology, by Type USD Million (2019-2024)
  • Table 224. Canada Diagnostic Technology, by Application USD Million (2019-2024)
  • Table 225. Canada Diagnostic Technology, by End User USD Million (2019-2024)
  • Table 226. Mexico Diagnostic Technology, by Type USD Million (2019-2024)
  • Table 227. Mexico Diagnostic Technology, by Application USD Million (2019-2024)
  • Table 228. Mexico Diagnostic Technology, by End User USD Million (2019-2024)
  • Table 229. Research Programs/Design for This Report
  • Table 230. Key Data Information from Secondary Sources
  • Table 231. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Diagnostic Technology: by Type USD Million (2013-2018)
  • Figure 5. Global Diagnostic Technology: by Application USD Million (2013-2018)
  • Figure 6. Global Diagnostic Technology: by End User USD Million (2013-2018)
  • Figure 7. South America Diagnostic Technology Share (%), by Country
  • Figure 8. Asia Pacific Diagnostic Technology Share (%), by Country
  • Figure 9. Europe Diagnostic Technology Share (%), by Country
  • Figure 10. MEA Diagnostic Technology Share (%), by Country
  • Figure 11. North America Diagnostic Technology Share (%), by Country
  • Figure 12. Global Diagnostic Technology share by Players 2018 (%)
  • Figure 13. Global Diagnostic Technology share by Players (Top 3) 2018(%)
  • Figure 14. Global Diagnostic Technology share by Players (Top 5) 2018(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Roche Diagnostics SpA (Italy) Revenue, Net Income and Gross profit
  • Figure 17. Roche Diagnostics SpA (Italy) Revenue: by Geography 2018
  • Figure 18. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 19. Danaher Corporation (United States) Revenue: by Geography 2018
  • Figure 20. Abbott Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Abbott Laboratories, Inc. (United States) Revenue: by Geography 2018
  • Figure 22. Siemens AG (United States) Revenue, Net Income and Gross profit
  • Figure 23. Siemens AG (United States) Revenue: by Geography 2018
  • Figure 24. Sysmex Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 25. Sysmex Corporation (Japan) Revenue: by Geography 2018
  • Figure 26. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 27. Thermo Fisher Scientific (United States) Revenue: by Geography 2018
  • Figure 28. Becton, Dickinson, and Company (United States) Revenue, Net Income and Gross profit
  • Figure 29. Becton, Dickinson, and Company (United States) Revenue: by Geography 2018
  • Figure 30. Biomérieux SA (France) Revenue, Net Income and Gross profit
  • Figure 31. Biomérieux SA (France) Revenue: by Geography 2018
  • Figure 32. Bio-Rad Laboratories, Inc. (France) Revenue, Net Income and Gross profit
  • Figure 33. Bio-Rad Laboratories, Inc. (France) Revenue: by Geography 2018
  • Figure 34. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 35. Johnson & Johnson (United States) Revenue: by Geography 2018
  • Figure 36. Global Diagnostic Technology: by Type USD Million (2013-2018)
  • Figure 37. Global Diagnostic Technology: by Application USD Million (2013-2018)
  • Figure 38. Global Diagnostic Technology: by End User USD Million (2013-2018)
  • Figure 39. South America Diagnostic Technology Share (%), by Country
  • Figure 40. Asia Pacific Diagnostic Technology Share (%), by Country
  • Figure 41. Europe Diagnostic Technology Share (%), by Country
  • Figure 42. MEA Diagnostic Technology Share (%), by Country
  • Figure 43. North America Diagnostic Technology Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Roche Diagnostics SpA (Italy)
  • Danaher Corporation (United States)
  • Abbott Laboratories, Inc. (United States)
  • Siemens AG (United States)
  • Sysmex Corporation (Japan)
  • Thermo Fisher Scientific (United States)
  • Becton, Dickinson, and Company (United States)
  • Biomérieux SA (France)
  • Bio-Rad Laboratories, Inc. (France)
  • Johnson & Johnson (United States)
Additional players considered in the study are as follows:
Diagnostic Technology Pty. Ltd. (Australia) , Agilent Technologies (United States) , QIAGEN GmbH (Germany) , Diasorin S.p.A (Italy) , Ortho Clinical Diagnostics (A Part of Carlyle Group) (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation